.jpg)
Get in Touch with the Vaccines Team
Learn more
HomeArticles
Latest Articles
Praluent® (alirocumab) Administration
Learn more
Therapeutic indications for Praluent® (alirocumab)
Learn more
Specific characteristics of Praluent® (alirocumab)
Learn more
NICE and SMC Guidance Praluent® (alirocumab)
Learn more
ODYSSEY OUTCOMES Safety Profile Praluent® (alirocumab)
Learn more
ESC/EAS DYSLIPIDAEMIA GUIDELINE INTERACTIVE (2 MINUTES)
We know your time is precious, how long do you have?
Learn more
ESC/EAS DYSLIPIDAEMIA GUIDELINE INTERACTIVE (1 HOUR)
We know your time is precious, how long do you have?
Learn more
ESC/EAS DYSLIPIDAEMIA GUIDELINE INTERACTIVE (20 MINUTES)
We know your time is precious, how long do you have?
Learn more
MAT-XU-2305061 (v2.0) Date of preparation: February 2024